Protalix BioTherapeutics (PLX) Total Debt (2011 - 2024)

Protalix BioTherapeutics (PLX) recorded quarterly Total Debt of $20.4 million in Q2 2024, little changed quarter-over-quarter from $20.4 million in Q1 2024.

Protalix BioTherapeutics (PLX) Total Debt (2011 - 2024) Analysis & Trends

Protalix BioTherapeutics' Total Debt history runs 11 years deep, the most recent figure standing at $20.4 million for Q2 2024.

  • In Q2 2024, Total Debt changed N/A year-over-year to $20.4 million; the TTM figure through Jun 2024 stood at $20.4 million (changed N/A YoY), while the FY2023 annual figure was $20.3 million, changed N/A from the prior year.
  • Total Debt was $20.4 million for Q2 2024 at Protalix BioTherapeutics, roughly flat from $20.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $56.4 million in Q2 2021 to a low of $3.2 million in Q3 2021.
  • Historically, Total Debt has averaged $31.3 million across 4 years, with a median of $20.4 million in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Protalix BioTherapeutics 176.47 Mn 165.67 Mn 29.62 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 20.42 Mn
Mar 31, 2024 20.42 Mn
Dec 31, 2023 20.25 Mn
Sep 30, 2023 20.19 Mn
Sep 30, 2021 3.24 Mn
Jun 30, 2021 56.36 Mn
Mar 31, 2021 55.37 Mn
Dec 31, 2020 54.43 Mn
Mar 31, 2018 5.93 Mn
Dec 31, 2017 5.92 Mn
Sep 30, 2017 10.21 Mn
Jun 30, 2017 4.30 Mn
Mar 31, 2017 4.30 Mn
Dec 31, 2016 58.17 Mn
Sep 30, 2016 4.30 Mn
Jun 30, 2016 4.30 Mn
Mar 31, 2016 4.30 Mn
Dec 31, 2015 4.30 Mn
Dec 31, 2013 2.37 Mn
Jun 30, 2013 376,000.00